Development
E
Cresco Labs Inc. CL
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 17.22% -418.77% 28.38% 33.65% 33.65%
Total Depreciation and Amortization 20.06% 24.04% 25.74% 31.46% 28.42%
Total Amortization of Deferred Charges 11.77% 11.79% -59.16% -62.46% -65.05%
Total Other Non-Cash Items -6.75% 680.60% -50.31% -51.43% -49.28%
Change in Net Operating Assets 13.11% 97.44% 511.70% 158.07% 146.28%
Cash from Operations 212.49% 24.13% 47.45% 1,451.89% 29.36%
Capital Expenditure 33.29% 26.98% 22.28% 37.08% 11.56%
Sale of Property, Plant, and Equipment 785.33% 486.24% -- -- --
Cash Acquisitions -- 100.00% 100.00% 99.93% 98.50%
Divestitures -- -- -- -- --
Other Investing Activities -101.95% -102.64% 267.36% 224.48% 713.47%
Cash from Investing -21.89% 32.39% 84.73% 86.56% 77.69%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -72.55% -77.09% 98.62% 98.81% 98.93%
Issuance of Common Stock -- -100.00% -96.02% -89.49% -97.77%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 50.94% 53.74% 54.70% -22.34% -25.26%
Cash from Financing 68.94% 71.08% -156.83% -197.39% -136.87%
Foreign Exchange rate Adjustments 45.13% 113.04% -85.37% 117.36% 51.08%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 87.58% 84.24% 59.15% -18.71% -222.58%